








SENTE Working Papers 35/2014
A Competence Set Approach 
and the Universities 
Human Spare Parts Industry  
as an Illustrative Case 
University of Tampere 







A	  Competence	  Set	  Approach	  and	  the	  Universities	  
Human	  Spare	  Parts	  Industry	  as	  an	  Illustrative	  Case	  
Paper	  presented	  at	  the	  PKU-­‐Stanford	  Forum	  
University	  as	  a	  Source	  of	  Innovation	  and	  Economic	  Development	  







Over	  time,	  the	  role	  of	  universities	  has	  evolved	  from	  a	  traditional	  focus	  on	  education	  and	  re-­‐
search	  to	  active	  participation	  in	  economic	  development	  processes.	  Accumulating	  empirical	  
evidence	  shows	  that	  universities	  contribute	  to	  economic	  development	  in	  a	  variety	  of	  ways	  
at	  all	  levels.	  This	  paper	  argues	  that	  the	  roles	  universities	  play	  in	  economic	  development	  and	  
innovation	   processes	   depend	   on	   the	   innovation	   ecosystems	   they	   are	   embedded	   into,	   as	  
well	  as	  the	  transformation	  processes	  occurring	  in	  them.	  Consequently,	  instead	  of	  solely	  fo-­‐
cusing	  on	  patenting,	   licensing	  and/or	  new	  business	   formation,	  both	   innovation	  policy	  and	  
universities	   would	   benefit	   from	   a	   more	   nuanced	   strategic	   awareness	   of	   the	   trajectories	  
along	  which	   industries	   evolve	   and	   the	   innovation	  processes	   that	   shape	   these	   trajectories	  
unfold.	  This	  paper	  suggests	  that	  to	  truly	  understand	  how	  industries	  evolve	  and	  change	  and	  
how	  universities	  contribute	   to	   their	   transformation,	   there	   is	  a	  need	   to	   focus	  on	  an	  entire	  
innovation	  ecosystem,	  and	  analyse	  interacting	  and	  conflicting	  competencies	  that	  either	  en-­‐
hance	  or	  hamper	  transformation	  processes.	  It	  is	  believed	  here	  that	  a	  competence	  set	  is	  the	  
core	  of	   any	   innovation	  ecosystem,	  but	   it	   is	   also	  believed	   that	  different	   competencies	   are	  
manifested	  in	  a	  variety	  of	  ways	  depending	  on	  the	  nature	  of	  the	  specific	  innovation	  ecosys-­‐
tem	  and	  related	  industries.	  	  
This	   paper	   sets	   to	   construct	   a	   focused	  model	   of	   innovation	   ecosystems	   that	   is	   based	   on	  
competence	  sets,	  and	  elaborate	  the	  key	  concepts	  and	  the	  theoretical	  framework	  related	  to	  
them.	  First,	   the	  concept	  of	   innovation	  ecosystem	   is	  briefly	   taken	  under	   scrutiny.	   It	   serves	  
the	   analysis	   as	   a	   guiding	  metaphor,	   providing	   the	   study	  with	   an	  overall	   understanding	  of	  
the	  organic	  and	  continuously	  evolving	  nature	  of	  relationships	  between	  main	  competencies	  
and	  between	  actors	  and	  their	  environment.	  Second,	  the	  view	  opened	  by	  the	  concept	  of	  in-­‐
novation	  ecosystem	  is	  complemented	  and	  specified	  by	  a	  scrutiny	  of	  competence	  sets,	  the	  
aim	  being	  to	  construct	  such	  a	  conceptual	  framework	  that	  serves	  future	  empirical	  analyses.	  







1.1 Background	  and	  rationale	  
Over	  the	  past	  two	  decades,	  universities	  have	  increasingly	  been	  seen	  as	  the	  core	  instruments	  of	  
local,	  regional	  and	  national	  economic	  development.	  All	  this	  seems	  new	  and	  fresh	  thinking	  but,	  
in	  practice,	  many	  universities	  have	  been	  involved	  in	  industrial	  and	  societal	  development	  for	  a	  
long	   time	   and,	   in	   some	  places,	   the	   primary	  motivation	   to	   establish	   a	   university	   has	   been	   to	  
serve	  economic	  development.	  The	  emergence	  of	   innovation	  policy	  across	  the	  globe	  as	  an	   in-­‐
creasingly	  visible	  form	  of	  public	  policy	  has	  hoisted	  the	  role	  of	  universities.	  This	  may	  be	  a	  result	  
of	  the	  observation	  that,	  as	  many	  traditional	  industries	  have	  been	  hollowing	  out,	  and	  as	  many	  
local	  economies	  have	  been	   losing	  their	   leading	   firms,	   the	  university	  often	  emerges	  as	  one	  of	  
the	  few	  solid	  and	  locally	  rooted	  resources	  to	  draw	  upon	  (Lester	  2007).	  Simultaneously,	  there	  is	  
an	   increasing	   understanding	   that	   innovation	   systems	   and	   policies	   need	   to	   be	   customized	   to	  
better	  serve	  the	  needs	  of	  the	  country	  or	  region	  in	  question	  (Tödtling	  and	  Trippl	  2005;	  Sotarau-­‐
ta	  and	  Kosonen	  2013).	  
Lester	  (2007,	  1)	  crystallizes	  the	   increased	  need	  to	   innovate	  by	  arguing	  that	  “the	  vigor	  and	  
dynamism	  of	  local	  economies	  depend	  on	  the	  ability	  of	  local	  firms	  to	  adapt	  to	  changing	  markets	  
and	   technologies	  by	   continually	   introducing	   commercially	   viable	  products,	   services,	   and	  pro-­‐
duction	  processes	  –	   that	   is,	  by	   innovating	   successfully”.	  He	  quite	   correctly	   reminds	  us	  about	  
the	  importance	  of	  strategic	  adaptation	  (Sotarauta	  and	  Srinivas	  2006).	  As	  Lester	  (2007,	  15)	  puts	  
it,	   “not	   all	   economies	   adapt	   to	   global	   economy	  with	  equal	   success,	   as	   the	   adaptive	   capacity	  
depends	  on	   the	  capabilities	  of	  many	  organisations	   to	   take	  up	  new	   technological	   and	  market	  
knowledge	   and	   to	   apply	   it	   effectively”.	   By	   now,	   it	   has	   become	   a	  well-­‐known	   fact	   that	  most	  
breakthrough	   innovations,	   and	  new	  businesses,	   are	  not	   created	   in	   isolation	  but	   through	  col-­‐
laborative	  arrangements	  that	  enable	  organizations	  to	  combine	  knowledge	  from	  many	  sources	  
and	  thus	  also	  integrate	  their	   individual	  offerings	  into	  coherent	  solutions.	  Strategic	  adaptation	  
is	   an	   interactive	   process.	   Inspired	   by	   these	   observations,	   the	   number	   of	   studies	   focusing	   on	  
different	  kinds	  of	   innovation	   (eco)systems	  has	  mounted	  during	   the	  past	  25	  years	   (see	  Fager-­‐
berg,	  Fosaas,	  and	  Saprasert	  2012).	  	  
This	  paper	  continues	  the	  work	  that	  began	  in	  the	  Local	   Innovation	  System	  project	   in	  which	  
the	  focus	  was	  on	  local	  capabilities	  for	  innovation	  (Lester	  2007).	  Capabilities	  for	  innovation	  re-­‐
fers	  to	  the	  ability	  to	  conceive,	  develop	  and/or	  produce	  new	  products	  and	  services,	  to	  deploy	  
new	  production	  processes,	  and	  to	   improve	  on	  those	   that	  already	  exist.	  Here,	   the	   focus	   is	  on	  
ecosystems	   and	   competence	   sets.	   The	   competence	   set	   model,	   being	   rooted	   in	   Eliasson’s	  
(2000)	  competence	  bloc	   theory,	   is	  used	  to	  specify	   the	  generic	   framework	  by	   focusing	  on	  the	  
competencies	  needed	  in	  innovation	  ecosystems.	  The	  competence	  bloc	  theory	  is	  a	  useful	  con-­‐
ceptual	   construction	   for	   an	   understanding	   of	   embryonic	   innovation	   ecosystems	   and	   indige-­‐
nous	  emergence	  of	  new	  industries,	  as	  this	  is	  exactly	  what	  it	  was	  designed	  for	  in	  the	  first	  place.	  
It	  may,	  however,	  offer	  a	   limited	  conceptual	  toolkit	   for	  the	  study	  of	  other	  types	  of	   innovation	  
ecosystems,	  and	  therefore	  it	   is	  here	  extended	  to	  cover	  additional	  competencies	  compared	  to	  




tence	  set	  instead	  of	  competence	  bloc.	  In	  line	  with	  its	  predecessor,	  the	  competence	  set	  model	  
focuses	   on	   the	  minimum	   set	   of	   actors	   with	   adequate	   competencies	   required	   in	   innovation,	  
business	  growth	  and	  economic	  renewal	  (Eliasson	  2000).	  	  
Universities	  are	  among	  the	  most	  important	  sources	  of	  highly	  educated	  people	  and	  new	  ide-­‐
as	   that	  are	  universally	   called	   for	   in	   the	  knowledge	  economy.	  However,	   the	  overall	  economic	  
significance	  of	  universities	  as	  sources	  of	  new	  business	  and	  innovation	  is	  often	  exaggerated.	  In	  
practice:	  (a)	  most	  well-­‐known	  cases	  of	  successful	  companies	  (Google,	  Cisco,	  etc.)	  directly	  relat-­‐
ed	  to	  universities	  are	  more	  atypical	  than	  typical	  examples;	  (b)	  business	  formation	  around	  uni-­‐
versity	  science	  and	  technology	   is	  a	  small	   fraction	  of	   the	  total	   rate	  of	  new	  business	  starts;	   (c)	  
universities	  are	  a	  minor	  contributor	  to	  the	  overall	  stock	  of	  patented	  knowledge;	  and	  (d)	  most	  
of	   the	   universities	   are	   not	   deriving	   significant	   financial	   benefits	   from	   technology	   transfer	  
(Lester	  2007).	  The	  economic	   significance	  of	  universities	   is	  high	  but	  more	  versatile	   than	  what	  
has	  been	  acknowledged	  by	  many	  of	   the	  policymakers.	  For	   these	   reasons	   this	  paper	  suggests	  
that	   to	   truly	   understand	   the	   economic	   role	   of	   universities	   in	   economic	   transformation,	   we	  
need	   to	   study	   it	   ‘outside	   in’,	   through	   economic	   trajectories	   of	   different	   types	   of	   innovation	  
ecosystems	  and	  by	  focusing	  on	  generic	  competencies	  called	  for	  in	  these	  processes.	  	  
This	  paper	  is	  based	  on	  the	  conceptual	  development	  and	  first	  empirical	  observations	  of	  the	  
on-­‐going	   research	  project	   ‘Innovation	  Ecosystems,	   Leadership	  and	   Innovation	  Policy’,	   funded	  
by	   the	   Finnish	   Funding	   Agency	   for	   Innovation	   (Tekes).	   It	   has	   set	   out	   to	   construct	   a	   focused	  
model	  of	  innovation	  ecosystems	  that	  is	  based	  on	  competence	  sets	  and	  elaborate	  the	  key	  con-­‐
cepts	   and	   the	   theoretical	   framework	   related	   to	   innovation	  ecosystems.	   First,	   the	   concept	  of	  
innovation	  ecosystem	  is	  briefly	  taken	  under	  scrutiny.	  It	  serves	  the	  analysis	  as	  a	  guiding	  meta-­‐
phor,	  providing	  the	  study	  with	  an	  overall	  understanding	  of	  the	  organic	  and	  continuously	  evolv-­‐
ing	   nature	   of	   relationships	   between	  main	   competencies	   and	   between	   actors	   and	   their	   envi-­‐
ronment.	  Second,	  the	  view	  opened	  by	  the	  concept	  of	  innovation	  ecosystem	  is	  complemented	  
and	  specified	  by	  a	  scrutiny	  of	  competence	  sets,	  the	  aim	  being	  to	  construct	  such	  a	  conceptual	  
framework	  that	  serves	  future	  empirical	  analyses.	  Third,	  the	  human	  spare	  parts	  industry	  is	  used	  
to	   highlight	   the	   competence	   set	  model.	   The	  main	   scientific	  motivation	   is	   to	   open	   a	   focused	  
view	  on	  innovation	  ecosystems	  and	  universities’	  roles	  in	  them	  by	  using	  the	  concept	  of	  compe-­‐
tence	  set	  as	  an	  intermediating	  framework.	  
1.2 Illustrative	  case:	  The	  emergence	  of	  the	  human	  spare	  parts	  industry	  in	  Tampere1	  
The	   emerging	   regenerative	  medicine	   concentration	   in	   Tampere	   and	   the	   prospective	   Finnish	  
human	  spare	  parts	  industry	  is	  used	  to	  highlight	  the	  conceptual	  discussion.	  The	  term	  regenera-­‐
tive	  medicine	  was	  coined	  in	  2000	  and	  is	  now	  widely	  used	  to	  describe	  biomedical	  approaches	  to	  
healing	   the	   body	   by	   the	   stimulation	   of	   endogenous	   cells	   to	   repair	   damaged	   tissues	   or	   the	  
transplantation	   of	   cells	   or	   engineered	   tissues	   to	   replace	   diseased	   or	   injured	   tissues	   (Riazi,	  
Kwon,	  and	  Stanford	  2009;	  see	  also	  Lysaght,	  Jaklenec,	  and	  Deweerd	  2008;	  Mason	  and	  Dunnill,	  
2008b).	   The	  basic	  unit	   in	   regenerative	  medicine	   is	   a	   stem	  cell.	   Stem	  cells	   are	  biological	   cells	  
found	  in	  all	  multicellular	  organisms.	  The	  potential	  of	  stem	  cells	  in	  clinical	  treatments	  is	  based	  
                                                




on	   their	  multipotent	   ability.	   Stem	  cells	   are	   able	   to	   regenerate	   tissues	   and	  organs	   and	  act	   as	  
building	  blocks	  for	  all	  tissues	  in	  the	  body	  (Nordforsk	  2007;	  National	  Institutes	  of	  Health	  2010).	  
Regenerative	  medicine	  has	  grown	  rapidly	   in	   the	  past	  decade	  and	  the	  scientific	  achievements	  
have	  created	  hopes	  of	  new	  treatments	  for	  severe	  incurable	  diseases,	  such	  as	  diabetes,	  Parkin-­‐
son’s	  disease,	  cancer	  and	  heart	  diseases.	  The	  promise	  of	  regenerative	  medicine	  is	  very	  exciting	  
but	  simultaneously	   the	  cost	  of	  product	  development,	  and	  most	  notably	  clinical	   trials,	   for	   the	  
high-­‐end	   applications	   is	   very	   high	   (Mason	   and	   Dunnill	   2008a,	   351).	   The	   term	   ‘human	   spare	  
parts	  industry’	  is	  a	  metaphor	  that	  describes	  the	  potential	  embedded	  in	  regenerative	  medicine.	  
For	  example,	  the	  City	  of	  Tampere	  has	  launched	  a	  vision	  that	  Tampere	  will	  become	  the	  center	  
of	  human	  spare	  parts	  in	  Finland.	  
In	  a	  way,	  the	  case	  of	  regenerative	  medicine	  in	  Tampere	  is	  a	  fairly	  straightforward	  one;	  the	  
universities	  have	  introduced	  a	  new	  technology	  and	  now	  it	  should	  be	  commercialized.	  We	  even	  
might	  be	  able	  to	  argue	  that	  the	  Universities	  in	  Tampere	  are	  well	  positioned	  in	  the	  emergence	  
of	  a	  new	  industry:	  human	  spare	  parts.	  But,	  this	  is	  not	  the	  full	  picture	  –	  not	  all	  the	  competen-­‐
cies	  are	  in	  place	  yet.	  The	  promise	  of	  regenerative	  medicine	  is	  very	  exciting	  as	  it	  may	  in	  the	  near	  
future	  introduce	  a	  fourth	  form	  of	  healthcare	  industry	  beside	  medical	  devices,	  pharmaceuticals	  
and	  biopharmaceuticals	  (Mason	  and	  Manzotti	  2009,	  783).	  	  
2 Innovation	  ecosystem	  
The	  rapidly	  mounting	  literature	  on	  innovation	  systems,	  and	  various	  variants	  related	  to	  it,	  have	  
significantly	   increased	  our	   understanding	   of	   the	  ways	   new	   knowledge	   is	   generated,	   diffused	  
and	  valorized	  to	  produce	  economic	  and/or	  social	  significance	  in	  different	  times	  and	  places	  (and	  
thus	  also	  about	  the	  roles	  universities	  play	  in	  the	  innovation	  puzzle).	  The	  concept	  of	  an	  innova-­‐
tion	  ecosystem	  instead	  of	  that	  of	  an	  innovation	  system	  is	  used	  here,	  the	  aim	  being	  to	  comple-­‐
ment	  the	  relatively	  established	  focus	  of	  (national,	  regional,	  sectoral)	  innovation	  system	  studies	  
that	  primarily	  address	  organizations	  (actors	  as	  components	  of	  systems),	  rules	  of	  the	  game	  (in-­‐
stitutions),	  interaction	  patterns	  (networks),	  innovation	  activities,	  knowledge	  flows	  and	  recently	  
also	  knowledge	  bases	  (see,	  e.g.,	  Asheim	  and	  Gertler	  2005;	  Asheim	  and	  Isaksen	  2002;	  Braczyk,	  
Cooke	  et	  al	  1997;	  Lundvall	  et	  al.	  2002;	  Sternberg	  et	  al	  2010).	  As	  Adner	  (2006)	  puts	  it,	  ecosys-­‐
tems,	  if	  they	  work	  well,	  allow	  firms	  to	  create	  value	  that	  no	  single	  firm	  could	  have	  done	  only	  by	  
itself.	  However,	  as	  Adner	  (2006)	  also	  reminds	  us,	  innovation	  ecosystems	  also	  present	  new	  sets	  
of	  risks	  for	  many	  firms.	  New	  interdependencies	  change	  the	  landscape	  in	  which	  firms	  and	  other	  
actors	  are	  embedded,	  and	  all	  this	  can	  cause	  increased	  uncertainty	  and	  generate	  surprises,	  as	  
ecosystems	  are	  not	  static	  and	  mechanical	  but	  constantly	  evolving	  organic	  entities.	  According	  
to	  Adner	  (2006),	  managers	  tend	  to	  overlook	  the	  ways	  ecosystems	  emerge	  and	  change	  all	  the	  
time.	   As	   an	   ecosystem	   is	   an	   organic	   and	   constantly	   evolving	   entity,	   actors	   cannot	   position	  
themselves	  as	  strategically	  as	  believed	  earlier	  but	  they	  need	  to	  coevolve	  with	  their	  ecosystem.	  
As	  observed	  by	  Papaioannou	  et	  al	  (2009),	  “ecosystems	  evolve	  through	  adaptation	  of	  living	  
organisms	  to	  their	  environment”.	  They	  argue	  further	  that	  this	  means	  that	  there	  is	  no	  need	  for	  
external	   intervention	  as	  ecosystems	  have	  an	   internal	  dynamic	   that	   reproduces	   the	   interrela-­‐




is	   not	   defined	   as	   something	   external	   to	   an	   innovation	   ecosystem	  but	   something	   that	   is	   em-­‐
bedded	  into	  it	  as	  one	  of	  the	  ‘living	  organisms’.	  From	  an	  innovation	  policy	  perspective,	  this	  view	  
is	   supported	   by	   the	   empirical	   observation	   that	   the	   borderline	   between	   policy	  making,	   firms	  
and	  other	  actors	  has	  been	  blurring,	  suggesting	  that	  universities	  are	  not	  the	  only	  beneficiaries	  
of	  a	  policy	  but	  active	  members	   in	   its	  design	   (Kuhlmann	  2001;	  Sotarauta	  and	  Kosonen	  2013).	  
Additionally,	   innovation	   ecosystems	   are	   assumed	   here	   to	   be	   multi-­‐locational	   in	   nature	   and	  
thus	   transnational	   networks,	   for	   their	   part,	   shape	   innovation	   ecosystems	   (cf.	   Crevoisier	   and	  
Jeannerat	   2009).	   Indeed,	   we	   cannot	   assume	   that	   all	   the	   functions	   and	   competencies	   of	   an	  
innovation	   ecosystem	   can	   be	   found,	   or	   can	   be	   constructed,	   in	   a	   single	   location,	   region	   or	  
sometimes	  even	  a	  nation.	  
Applying	  our	  earlier	   study	  on	  universities’	   roles	   in	   local	   innovation	   systems	   (Lester,	  2005;	  
Lester	  and	  Sotarauta,	  2007)	  and	  self-­‐renewal	  capacity	  (Sotarauta	  2009),	   it	   is	  possible	  to	  cate-­‐
gorize	  innovation	  ecosystems	  and	  their	  evolution	  as	  follows.	  
Embryonic	  and	  fragile	  innovation	  ecosystem	  –	  indigenous	  emergence	  of	  a	  new	  industry	  
• The	  emergence	  of	  an	  innovation	  ecosystem	  in	  a	  field	  that	  has	  no	  direct	  antecedent	  in	  
the	  economy.	  It	  entails	  the	  creation	  of	  new	  capabilities	  and/or	  major	  transformation	  
of	  existing	  ones	  to	  support	  the	  enlargement	  of	  an	  embryonic	  ecosystem	  and	  thus	  also	  
new	  industry.	  
• This	   type	   entails	   an	   incumbent	   industry	   that	   has	   some	   fragments	   of	   an	   ecosystem	  
around	  it	  and	  some	  functions	  in	  place,	  but	  that	  has	  not	  developed	  as	  a	  system	  but	  on-­‐
ly	  as	  individual	  elements;	  thus,	  some	  fragmented	  pieces	  of	  competence	  blocs	  may	  ex-­‐
ist	  but	  several	  pieces	  are	  missing	  and/or	  have	  not	  been	  tapped	  into	  internationally.	  
An	  existing	   innovation	   ecosystem	  adjusts	   to	   a	  major	   firm	   relocating	   or	   to	   an	   industry	  
imported	  from	  elsewhere	  
• This	  type	  of	  trajectory	  introduces	  an	  industry	  that	  is	  new	  to	  the	  economy.	  The	  primary	  
mechanism	  is	  the	  importation	  of	  the	  industry	  from	  elsewhere,	  and	  thus	  the	  question	  
of	  whether	  there	  is	  an	  ecosystem	  that	  is	  ready	  to	  support	  the	  new	  industry	  becomes	  
relevant,	   or	   whether	   an	   existing	   ecosystem	   is	   able	   to	   adjust	   itself	   to	   support	   new	  
transplanted	  firms	  and	  thus	  antecedent	  of	  a	  wider	  industry.	  
An	  innovation	  ecosystem	  in	  transformation,	  diversifying	  into	  related	  industries	  	  
• This	  category	  refers	  to	  transitions	   in	  which	  an	  existing	   industry	  declines,	  but	   its	  core	  
technologies	   and/or	   competencies	   are	   redeployed	   and	   provide	   the	   basis	   for	   the	  
emergence	  of	  a	  related	  new	  innovation	  ecosystem	  and	  an	  industry	  stemming	  out	  of	  it.	  
This	  also	  entails	  the	  upgrading	  and	  enlarging	  of	  an	  ecosystem	  through	  major	  changes	  
in	  its	  core	  capabilities,	  and	  also	  the	  introduction	  of	  new	  actors	  as	  well	  as	  the	  deactiva-­‐
tion	  of	  others.	  
• This	   category	   also	   refers	   to	   an	   existing	   technology	   that	   is	   exploited	   in	   new	  ways	   in	  
other	  industries.	  
Upgrading	  of	  an	   innovation	  ecosystem	  to	  support	  the	   internal	  renewal	  of	  an	  existing	  
industry	  
• This	  type	  entails	  the	  upgrading	  of	  an	  incumbent	  industry	  through	  the	  infusion	  of	  new	  
technologies	   or	   product	   or	   service	   enhancements.	   It	   also	   involves	   customization	   of	  




The	  human	  spare	  parts	  industry	  clearly	  belongs	  to	  the	  category	  of	  embryonic	  and	  fragile	  inno-­‐
vation	  ecosystem.	  The	  other	  innovation	  ecosystem	  types	  are	  not	  discussed	  here.	  
3 A	  competence	  set	  model	  
3.1 A	  competence	  bloc	  theory	  and	  the	  concept	  of	  competence	  
The	  competence	  set	  model	   is	  highly	   inspired	  by	  the	  competence	  bloc	  theory	  (Eliasson	  2000),	  
but	  as	  the	  competence	  bloc	  theory	  was	  constructed	  mainly	  to	  better	  understand	  and	  explain	  
business	   growth	   in	   biotechnology,	   it	   needs	   to	   be	   extended	  with	   additional	   competencies	   to	  
provide	  an	  analytical	  tool	  also	  for	  analysis	  of	  other	  innovation	  ecosystem	  types.	  Before	  discuss-­‐
ing	   the	  extension,	   the	  concept	  of	  competence	   is	  defined	  and	   the	  basic	   tenets	  of	   the	  original	  
competence	  bloc	  theory	  are	  introduced.	  
It	  is	  assumed	  here	  that	  to	  better	  understand	  how	  universities	  contribute	  to	  different	  types	  
of	   innovation	   ecosystems,	   there	   should	   be	   more	   emphasis	   on	   interacting	   competencies	   in-­‐
stead	   of	   interacting	   actors.	   Additionally,	   it	   is	   assumed,	   following	   Avnimelech	   and	   Teubal	  
(2008),	   that	  our	  understanding	  of	   innovation	  systems,	  universities’	   roles	   in	   them	  and	  related	  
innovation	   policies	   ought	   to	   be	   dynamic	   and	   systems-­‐evolutionary	   by	   nature	   to	   effectively	  
trigger,	   reinforce	   and	   sustain	  market-­‐led	   evolutionary	   processes	   of	   the	   economy.	   For	   these	  
reasons,	   the	  main	   rationale	   in	   constructing	   a	   competence	   set	  model	   is	   to:	   (a)	   specify	   what	  
competencies	  various	  actors	  bring	   into	  play	   in	  an	   innovation	  ecosystem;	  and	   (b)	   identify	   the	  
competencies	  that	  keep	  an	  innovation	  ecosystem	  continuously	  adapting	  to	  changing	  economic	  
landscapes,	  and	  thus	  renewing	  economies.	  A	  sole	   focus	  on	  actors	  and	  relationships	  between	  
them,	  so	  typical	  in	  innovation	  system	  studies,	  may	  even	  blur	  the	  view	  on	  how	  systems	  actually	  
function	  and	  what	  drives	  them,	  and	  hence	  it	  is	  important	  to	  make	  a	  distinction	  between	  organ-­‐
izations	  and	  competencies.	  As	  many	  organizations	  are	  large	  and	  heterogeneous	  entities	  (most	  
notably	  universities)	  and	  have	  multiple	  roles,	  and	  consequently	  also	  multiple	  goals	  and	  expec-­‐
tations,	  they	  may	  have	  many	  competencies	  that	  contribute	  to	  an	  innovation	  ecosystem.	  All	  in	  
all,	  by	  approaching	  actors	   indirectly	  through	  competencies	   it	  might	  be	  possible	  to	  clarify	  and	  
specify	  the	  roles	  they	  play	  in	  translating	  new	  knowledge	  to	  viable	  products	  and	  services.	  	  
In	   innovation	   ecosystems,	   competencies	   (in	   direct	   and/or	   indirect	   interaction)	   generate,	  
stimulate	   and/or	   frame	   the	   overall	   functioning	   of	   a	   system	   and	   its	   transformation	   (Eliasson	  
2000).	  Additionally,	  it	  may	  also	  be	  the	  case	  that	  an	  innovation	  ecosystem	  as	  a	  whole,	  or	  some	  
competencies	  of	  it,	  is	  not	  at	  an	  adequate	  level.	  Missing	  and/or	  poor	  competencies	  may	  freeze	  
an	  innovation	  ecosystem	  and	  lock	  it	  in	  the	  past,	  and	  thus	  the	  question	  may	  not	  only	  be	  about	  
lack	  of	  an	  actor	  and/or	  policy	  tool	  of	  some	  kind,	  as	  is	  often	  seen.	  In	  organization	  and	  manage-­‐
ment	   studies,	   the	   concept	   of	   core	   competence	   has	   become	   one	   of	   the	   key	   concepts	   in	   the	  
efforts	  to	  understand	  why	  some	  firms	  succeed	  while	  others	  do	  not.	  The	  basic	   idea	   is	   that	  an	  
organization	   should	   comprehend	   its	   own	   core	   competencies	   and	   capabilities	   in	   order	   to	   be	  
able	   to	   utilize	   the	   resources	   available	   (Pralahad	   and	  Hamel	   1990).	   Additionally,	   it	   is	   also	   as-­‐
sumed	  that	  competencies	  change	  more	  slowly	  than	  products	  and	  markets.	  Thus	  the	  identity	  of	  




something	  that	   lies	  at	  the	  very	  core	  of	  the	  organization’s	  activities	  and	  success	   (Tuomi	  1999,	  
82–83).	  All	  innovation	  ecosystems	  have	  resources,	  but	  by	  no	  means	  all	  of	  them	  are	  capable	  of	  
utilizing	  these	  efficiently.	  Mere	  resources	  are	  frequently	  not	  enough	  to	  generate	  competitive-­‐
ness,	   let	   alone	   to	   create	   a	   sustainable	   competitive	   advantage.	   Creating	   a	   competitive	   ad-­‐
vantage	  generally	  requires	  the	  ability	  to	  make	  good	  use	  of	  resources,	  i.e.,	  capability	  to	  handle	  
a	  given	  matter	  and	  utilize	  the	  available	  resources	  and	  to	  create	  new	  ones.	  Durand	  (1998,	  306)	  
connects	   competencies:	   (a)	   directly	   to	   an	   organization’s	   resources	   and	   property;	   and	   (b)	   to	  
individual	  and	  organizational	  capabilities,	  knowledge,	  processes,	  routines	  and	  culture.	  Javidan	  
(1998,	  62)	  uses	  competence	  to	  refer	  to	  the	  combining	  and	  coordinating	  of	  capabilities	  cutting	  
across	  functions.	  In	  organizations	  with	  many	  fields,	  competencies	  are	  thus	  sets	  of	  specific	  ca-­‐
pabilities.	  Competence	  is	  here	  taken	  to	  be	  specifically	  capability	  and	  expertise	  that	  is	  potential-­‐
ly	  common	  to	  several	  organizations	  in	  an	  innovation	  ecosystem	  but	  that	  at	  all	  events	  is	  shared	  
in	  an	  organization	  having	  a	  central	  position	  in	  an	  ecosystem.	  Competencies	  are	  thus	  distribut-­‐
ed	  over	  many	  operations	  either	  within	  an	  organization	  or	  across	  them.	  Core	  competence,	  ap-­‐
plying	  the	  theory	  of	  Pralahad	  and	  Hamel	  (1990),	  is	  predominantly	  a	  collective	  learning	  process	  
across	  the	  innovation	  ecosystem,	  and	  thus	  much	  more	  than	  simply	  what	  an	  individual	  organi-­‐
zation	  is	  good	  at.	  A	  core	  competence	  of	  an	  innovation	  ecosystem	  differentiates	  it	  from	  other	  
ecosystems.	  
In	  innovation	  ecosystems,	  competence	  is	  a	  nested	  concept	  that	  covers	  capabilities	  of	  indi-­‐
viduals,	   organizations	   and	   entire	   systems.	   A	   competence	   set	  model	   is	   geared	   to	   identifying	  
how	  different	  capabilities	  of	  many	  actors	  could	  be	  integrated	  with	  one	  another	  so	  that	  such	  a	  
constructed	  set	  would	  serve	  both	  the	  entire	  ecosystem	  and	  actors	  embedded	  into	  it.	  The	  com-­‐
petence	  set	  might	  also	  serve	  as	  a	  tool	  in	  a	  search	  for	  shared	  interests,	  problems,	  opportunities	  
and	  capabilities	  (cf.	  Pralahad	  and	  Hamel	  1990).	  It	  therefore	  follows	  that	  a	  competence	  set	  is	  a	  
collection	  of	  generic	  competencies	  widely	  distributed	  within	  an	  innovation	  ecosystem.	  Apply-­‐
ing	  Eliasson’s	  (2000)	  thought,	  the	  competence	  set	   is	  defined	  as	  a	  configuration	  of	  competen-­‐
cies	  that	  in	  direct	  and	  indirect	  interaction	  generates	  new	  knowledge	  as	  well	  as	  its	  diffusion	  and	  
valorization.	  Thus	  generated,	  new	  knowledge	  is	   linked	  to	  business	  growth,	  economic	  renewal	  
and/or	  societal	  change	  through	  other	  competencies.	  Basically	  the	  competence	  set	  refers	  to	  an	  
ability	  to	  achieve	  new	  forms	  of	  competitive	  advantage	  by	  highlighting	  the	  need	  to	  continuously	  
renew	  competencies	  so	  as	  to	  achieve	  congruence	  with	  the	  changing	  environment.	  This	  notion	  
is	  in	  line	  with	  Teece’s	  et	  al	  (1997)	  dynamic	  capabilities	  theory	  that	  emphasizes	  the	  key	  role	  of	  
strategic	   management	   in	   appropriately	   adapting,	   integrating	   and	   reconfiguring	   internal	   and	  
external	   organizational	   skills,	   resources	   and	   functional	   competencies	   to	   match	   the	   require-­‐
ments	  of	  a	  changing	  environment.	  The	  competence	  and	  dynamic	  capabilities	  theories	  focus	  on	  
‘the	   firm’	  while	   the	  competence	  set	  model	   is	  more	   interested	   in	   ‘the	  system’,	  and	   therefore	  
the	  question	  of	  strategic	  management	  appears	  as	  very	  different.	  In	  a	  system,	  there	  is	  no	  single	  
controlling	  strategic	  leadership	  but	  a	  network	  of	  interdependent	  actors.	  
According	  to	  Eliasson	  (2000),	  the	  prime	  function	  of	  a	  competence	  bloc	  “is	  to	  guide	  the	  se-­‐
lection	  of	  successful	  innovations	  through	  its	  competence	  filter,	   induced	  by	  incentives	  and	  en-­‐




production	   and	   distribution”.	   Therefore,	   the	   competence	   of	   actors	   and	   their	   interaction	   de-­‐
termines	   the	   quality	   of	   a	   competence	   set	   and,	   as	   assumed	   here,	   also	   that	   of	   an	   innovation	  
ecosystem.	  As	  Eliasson	  (2000)	  also	  says,	  a	  competence	  bloc	  is	  defined	  through	  its	  end	  results,	  
i.e.	   “through	  a	  bundle	  of	   functionally	   related	  products	  and	   services	   in	   the	  market	  but	  not	   in	  
terms	  of	  technologies	  or	  physical	  inputs”.	  Additionally,	  a	  competence	  bloc	  attracts	  competent	  
investors	  who	   contribute	  positively	   to	   the	  attractiveness	  of	   the	   competence	  bloc,	   and	   those	  
whose	  contribution	  is	  not	  positive	  for	  the	  entire	  ecosystem	  are	  not	  selected.	  A	  minimum	  criti-­‐
cal	   competence	   mass	   and	   variety	   are	   needed	   before	   a	   competence	   set	   bloc	   becomes	   self-­‐
propelled	  into	  a	  growing	  industry.	  The	  policy	  problem	  therefore	  concerns	  whether	  policy	  cata-­‐
lysts	  can	  be	  inserted	  to	  initiate	  a	  competence	  set	  bloc	  and/or	  induce	  it	  to	  boost	  an	  innovation	  
ecosystem	  to	  reach	  critical	  mass	   faster	  and/or	  whether	  such	  catalysts	  are	  to	  be	  found	   in	  the	  
science	  and/or	  business	  community.	  	  
According	   to	   Eliasson	   and	   Eliasson	   (1996),	   the	   following	   actors	   constitute	   a	   competence	  
bloc	  (modified	  slightly):	  
• competent	  and	  active	  customers	  and	  users	  
• innovators	  who	  combine	  new	  knowledge	  and	  technologies	  in	  novel	  ways	  	  
• entrepreneurs	  who	   identify	  profitable	   innovations	  and	  prepare	  them	  for	   initiation	   in	  
the	  market	  
• competent	  venture	  financiers	  who	  recognize	  and	  finance	  the	  entrepreneurs	  
• exit	  markets	  that	  facilitate	  ownership	  change	  
• industrialists	  and	  other	  established	  actors	  who	  take	  successful	  innovations	  to	  industri-­‐
al-­‐scale	  production.	  
3.2 The	  human	  spare	  parts	  industry	  discussed	  through	  a	  competence	  set2	  
Eliasson	   (2000)	   associates	   competence	   blocs	   strongly	   with	   that	   part	   of	   the	   ecosystem	   that	  
influences	  the	  selection	  of	  winning	  technologies	  and	  corporate	  winners,	  and	  conversely	  losing	  
technologies	  and	  corporations.	  He	  points	  out	  that	  the	  selection	  involves	  the	  joint	  minimization	  
of	  two	  errors:	  (1)	  to	  allow	  losers	  to	  survive	  for	  too	  long;	  and	  (2)	  to	  reject	  winners.	  However,	  an	  
innovation	  ecosystem	  is	  not	  only	  about	  selection	  of	  ‘winners’	  and	  ‘losers’	  but	  more	  profoundly	  
and	   broadly	   about	   economic	   renewal,	   and	   thus	   the	   question	   is	   about	   how	   new	   knowledge	  
emerges,	  how	  it	  generates	  variation	  and	  how	  selection	  is	  made,	  and	  thus	  the	  original	  theory	  is	  
extended	  to	  also	  cover	  other	  competencies.	  The	  rationale	   in	  extending	  the	  competence	  bloc	  
theory	  is	  to	  better	  cover	  all	  three	  main	  functions	  put	  forward	  by	  the	  evolutionary	  theory.	  They	  
are:	  (a)	  retention	  and	  transmission	  of	  information;	  (b)	  generation	  of	  novelty	  leading	  to	  diversi-­‐
                                                
2	  Instead	  of	  using	  ‘bloc’	  this	  paper	  adopts	  ‘set’	  to	  highlight	  the	  collection	  of	  competencies	  that	  belong	  together	  or	  
are	  otherwise	   found	   together.	   This	   is	   only	   to	   simplify	   the	  discussion,	   as	   ‘bloc’	   is	   often	  understood	   to	   refer	   “to	   a	  
group	  of	  countries	  or	  political	  parties	  with	  common	   interests	  who	  have	  formed	  an	  alliance”	  or	  “a	  combination	  of	  
persons,	   groups,	   or	   nations	   forming	   a	   unit	   with	   a	   common	   interest	   or	   purpose”	   (Merriam-­‐Webster	   Dictionary).	  
‘Bloc’	  may	   also	   be	   confused	  with	   ‘block’,	  which	   refers	   to	   “an	   obstacle	   to	   the	   normal	   progress	   or	   functioning	   of	  
something”.	  For	  its	  part,	  ‘set’	  refers	  to	  “a	  group	  or	  collection	  of	  things	  that	  belong	  together	  or	  resemble	  one	  anoth-­‐
er	  or	  are	  usually	   found	   together”	   (Merriam-­‐Webster	  Dictionary).	   In	  practice,	   the	  competence	  set	  model	   is	  an	  ex-­‐





ty;	  and	  (c)	  selection	  among	  alternatives	  (McKelvey	  1997).	  The	  competence	  set	  model	  reminds	  
us	  that	  capabilities	  are	  the	  core	  in	  any	  effort	  to	  sustain,	  renew	  and/or	  create	  new	  knowledge	  
for	  economic	  renewal.	  The	  value	  of	  thinking	  competencies	  in	  the	  context	  of	  innovation	  ecosys-­‐
tems	  is	  that:	  (a)	  it	  acknowledges	  the	  need	  to	  understand	  how	  complementing	  and	  conflicting	  
knowledge,	  resources	  and	  abilities	  of	  different	  actors	  influence	  each	  other;	  but	  it	  also	  reminds	  
that	   (b)	   these	   can	   be	   consciously	   reconfigured,	   redirected,	   transformed	   and	   appropriately	  
shaped,	  and	  integrated	  into	  existing	  competencies	  as	  well	  as	  external	  resources	  (cf.	  Teece	  et	  al	  
1997).	  	  
Next,	   drawing	   upon	   literature	   on	   innovation	   systems	   and	   functions	   related	   to	   them,	   the	  
competence	   bloc	   theory	   is	   extended	   to	   also	   cover	   legitimization	   and	  market	   formation,	   and	  
some	  of	   the	  original	   components	  of	   the	  competence	  bloc	   theory	  are	  put	   slightly	   in	  different	  
light.	  The	  competence	  set	  model	  covers	  seven	  generic	  competencies.	  They	  are	  related	  to:	  (1)	  
knowledge	  creation,	  diffusion	  and	  valorization;	  (2)	  entrepreneurship;	  (3)	  venture	  finances;	  (4)	  
legitimization;	   (5)	  market	   formation;	   (6)	   systematic	   production;	   and	   (7)	   identifying	   potential	  
end-­‐values.	   The	   seven	   generic	   competencies	   in	   conjunction	   form	   a	   competence	   set.	   Quite	  
naturally,	  each	  of	  these	  includes	  a	  variety	  of	  specific	  capabilities	  that,	  for	  their	  part,	  construct	  
the	  generic	   competencies.	   In	  a	   system-­‐level	  analysis,	   the	   interaction	  of	   identified	  competen-­‐
cies	  provides	  further	  empirical	  analysis	  with	  a	  point	  of	  departure	  to	  identify	  the	  specific	  capa-­‐
bilities	  in	  a	  context	  of	  a	  specific	  transformation	  process	  of	  a	  specific	  innovation	  ecosystem.	  The	  
illustrative	  case,	  the	  human	  spare	  parts	   industry,	   is	  discussed	  through	  a	  competence	  set	  and,	  
conversely,	  seven	  generic	  competencies	  are	  discussed	  through	  the	  case.	  	  
	  
	  
FIGURE	  1.	  The	  competence	  set	  model.	  
Knowledge	   creation	   is	   an	   obvious	   generic	   competence	   in	   any	   innovation	   ecosystem.	   Quite	  
naturally,	  the	  exchange	  and	  diffusion	  of	  knowledge	  are	  also	  of	  importance.	  If	  new	  knowledge	  
does	  not	  circulate	  in	  an	  ecosystem,	  the	  lead	  idea	  of	  it	  becomes	  superfluous.	  Knowledge	  crea-­‐






















lead	   to	   increased	   diversity.	   As	   research	   related	   to	   regenerative	  medicine,	   side	   by	   side	   with	  
other	  branches	  of	  biomaterial	  research,	  has	  become	  institutionalized	  rapidly	   in	  Tampere	  (see	  
Sotarauta	  and	  Mustikkamäki,	  forthcoming),	  the	  knowledge	  core	  of	  the	  human	  spare	  parts	   in-­‐
dustry	   has	   developed	   favourably.	   The	   constructed	   knowledge	   concentration	   is	   based	   on	   a	  
close	  collaboration	  between	   the	  University	  of	  Tampere	  and	   the	  Tampere	  University	  of	  Tech-­‐
nology,	  and	  it	  has	  produced	  scientific	  breakthroughs	  most	  notably	  in	  facial	  bone	  replacements.	  
The	   first	   discoveries	  were	   based	   on	   collaboration	   between	   biomaterial	   engineers,	   clinicians,	  
cell	   biologists,	   technical	   experts	   and	   animal	   model	   experts	   (Sotarauta	   and	   Mustikkamäki,	  
forthcoming).	  
It	  would	  not	  be	  an	  overstatement	   to	   say	   that	   the	   creation	  of	   scientific	   knowledge	   is	   at	   a	  
high	   level.	  The	  unique	  nature	  of	  science	  and	  technology	  can	  be	   illustrated	  by	  the	  fact	  that	   in	  
2008,	  for	  the	  first	  time	  in	  the	  world,	  a	  patient’s	  upper	  jaw	  was	  replaced	  with	  a	  bone	  transplant	  
cultivated	  from	  the	  stem	  cells	  isolated	  from	  the	  patient’s	  own	  fatty	  tissue	  (Sotarauta	  and	  Mus-­‐
tikkamäki,	  forthcoming).	  The	  patient	  had	  lost	  roughly	  half	  of	  his	  upper	  jaw	  because	  of	  cancer	  
and	  traditional	  medicine	  was	  unable	  to	  offer	  remedial	  treatment.	  In	  the	  process,	  the	  scientists	  
were	  able	  to	  produce	  new	  bone	  cells	  by	  combining	  stem	  cells	  and	  biomaterials	  and	  then	  grow-­‐
ing	  them	  into	  a	  jawbone	  of	  the	  correct	  shape	  and	  size	  (with	  the	  aid	  of	  a	  titanium	  frame)	  inside	  
the	   patient’s	   stomach	   muscle	   (Suomen	   Kuvalehti	   2008;	   Bionext	   2010;	   Sotarauta	   and	   Mus-­‐
tikkamäki,	   forthcoming).	   This	   operation	   was	   a	   continuation	   of	   successful	   clinical	   treatments	  
undertaken	   in	   2007,	   in	  which	   two	  patients	  with	  bone	  deficiencies	  were	   treated,	   jointly	  with	  
the	  Tampere	  University	  Hospital,	  with	  a	  combination	  of	  fat	  stem	  cells	  and	  biomaterials.	  By	  the	  
end	  of	  2010,	  based	  on	  this	  technology,	  approximately	  30	  patients	  with	  serious	  bone	  deficien-­‐
cies	  had	  been	  treated	  in	  Finnish	  hospitals	  (Bionext	  2010).	  In	  comparison,	  by	  early	  2010,	  analo-­‐
gous	   treatment	   (external	   to	   the	  Tampere	  network)	  has	  been	  received	  by	  only	  one	  patient	   in	  
Germany	  (Tekes	  2010).	  Beyond	  any	  doubt,	  knowledge	  creation	  is	  at	  a	  high	  level	  and	  the	  clinical	  
experimentations	  have	  been	  successful.	  The	  questions	  that	  have	  not	  yet	  been	  answered	  are:	  
(a)	  How	  could	   the	   revolutionary	   technology	  become	  a	  permanent	   element	  of	  hospital	   treat-­‐
ments?,	  and	  (b)	  What	   is	  needed	  to	  move	  from	  individual	  treatments	  to	  a	  human	  spare	  parts	  
industry?	  	  
These	  are	  tricky	  questions,	  as	  the	  industry	  is	  globally	  in	  an	  embryonic	  state,	  and	  therefore	  
the	   issue	  of	  how	  to	  move	  from	  research	  and	  development	  to	  systematic	  production	  has	  not	  
been	  answered	  yet.	  The	  concept	  of	  systematic	  production	   is	  used	  here	   instead	  of	   large-­‐scale	  
production	   as	   some	   innovations	   related	   to	   regenerative	   medicine	   may	   find	   their	   place	   in	  
smaller-­‐scale	   production	   systems.	   The	   main	   question	   is	   whether	   they	   become,	   one	   way	   or	  
another,	   a	   permanent	   element	   of	   the	   health-­‐care	   system	   and	   the	   economy	   or	   not.	   Science	  
developing	   favourably,	   the	   pressure	   to	   detect	   commercially	   viable	   products	   and	   services	   is	  
increasing	  steadily.	  The	  prospective	  human	  spare	  parts	   industry	   is	  deeply	  embedded	  into	  sci-­‐
entific	  research,	  and	  thus	  it	  is	  imperative	  for	  the	  firms	  operating	  in	  the	  field	  to	  have	  access	  to	  
cutting	  edge	  research	  (Prescott	  2011).	  Conversely,	  according	  to	  Heinonen	  (forthcoming),	  uni-­‐
versities	  are	  expected	  to	  nurture	  innovations	  further	  into	  clinical	  trials	  before	  aiming	  to	  estab-­‐




been	  established	  to	  fund	  clinical	  trials	   (Mason	  et	  al	  2011).	  Any	  effort	  to	  construct	  systematic	  
production	  calls	  for	  close	  collaboration	  between	  scientist	  and	  entrepreneurs,	  as	  well	  as	  hospi-­‐
tals	   –	   in	   practice	   between	   their	   differing	   competencies	   are	   called	   for.	   As	   the	   universities	   in	  
Tampere	  do	  not	  have	  competencies	  to	  move	  forward	  in	  systematic	  production,	  the	  competen-­‐
cies	  of	  entrepreneurs	  and/or	  hospitals	  are	  called	  for.	  
As	  entrepreneurs	  take	  advantage	  of	  new	  business	  opportunities	  generated	  by	  themselves	  
and/or	  new	  knowledge,	  and	  as	  they	  turn	  the	  potential	  of	  new	  knowledge,	  networks	  and	  mar-­‐
kets	  into	  new	  business	  opportunities	  (Hekkert	  et	  al	  2007),	  their	  competencies	  related	  to	  mar-­‐
ket	  understanding	  and	  creation	  may	  be	  of	   importance	   in	  moving	  towards	  systematic	  produc-­‐
tion,	  also	  in	  regenerative	  medicine.	  In	  addition,	  entrepreneurs	  possess	  competencies	  that	  en-­‐
hance	  generation	  of	  diversity	  and	  diffusion	  of	  new	  knowledge.	  Entrepreneurial	  activity	   is	  one	  
of	  the	  core	  activities	  in	  selecting	  viable	  alternatives	  from	  emerging	  ideas	  and	  knowledge.	  How-­‐
ever,	   in	  the	  case	  of	  the	  emerging	  human	  spare	  parts	   industry,	   it	  may	  well	  be	  that	  competen-­‐
cies	  related	  to	  institutional	  entrepreneurship	  may	  be	  needed	  to	  change	  the	  hospital	  practices	  
to	   take	   full	   advantage	  of	   the	  emerging	   field	  of	  medicine.	   It	   is	  hard	   to	   imagine	  an	   innovation	  
ecosystem,	  and	  entrepreneurship	  related	  to	  it,	  without	  discussions	  of	  venture	  finances.	  A	  well-­‐
functioning	   innovation	   ecosystem	   requires	   competent	   venture	   financiers	  who	   recognize	   and	  
finance	   the	  entrepreneurs,	   and	  hence,	   for	   their	  part,	   play	  an	   important	   role	   in	   the	   selection	  
process.	   It	  has	  been	  shown	  that	  the	  catalytic	  role	  of	  venture	  financiers	   is	  often	  crucial	   in	  the	  
emergence	  of	  new	  industries.	  	  
As	  regenerative	  medicine	  and	  the	  related	  human	  spare	  parts	  industry	  is	  still	  in	  an	  embryon-­‐
ic	  and	  emergent	  stage,	  funding	  is	  largely	  dependent	  on	  public	  funding,	  philanthropists	  and	  also	  
military-­‐related	  funding	  (Mason	  2007;	  cited	  in	  Heinonen,	  forthcoming)	  Regenerative	  medicine	  
is	  a	  fairly	  typical	  case	  of	  an	  emerging	  science-­‐based	  field	  that	  draws	  heavily	  on	  public	  funding,	  
and	  private	  venture	  financiers	  become	  interested	  in	  the	  potential	  of	  its	  innovations	  only	  in	  the	  
later	  phases	  of	  clinical	  trials	  (Parson	  2008).	  Competencies	  related	  to	  knowledge	  development	  
and	  diffusion	  have	  been	   strengthening	   steadily	   in	  Tampere,	  and	  public	   funding	  has	  been	  ex-­‐
tensively	  received	  to	  support	  emergence	  of	  regenerative	  medicine	  but	  private	  venture	  finance	  
has	  not	  found	  its	  way	  to	  Tampere,	  or	  it	  has	  not	  been	  allowed	  to	  do	  so	  yet.	  All	  this	  may	  be	  due	  
to	  the	  fact	  that,	  in	  spite	  of	  the	  huge	  promises,	  the	  market	  for	  the	  human	  spare	  parts	  industry	  is	  
still	  to	  emerge,	  and	  therefore	  the	  competent	  companies	  and	  entrepreneurs	  have	  not	  seen	  the	  
business	  opportunity	  yet.	  	  
Fairly	  often	  the	  issues	  related	  to	  ways	  how	  new	  markets	  emerge	  and	  existing	  ones	  change	  
are	  not	  considered	  as	  elements	  of	  innovation	  ecosystems	  in	  the	  literature.	  Nor	  are	  competen-­‐
cies	   related	   to	   how	  market	   formation	   can	   be	   influenced	   and/or	   understood	   linked	   to	   other	  
relevant	  competencies.	  But,	  it	  is	  a	  well-­‐known	  fact	  that,	  in	  many	  fields,	  radical	  innovations	  do	  
not	   penetrate	   economies	   without	   emergence	   of	   a	   new	  market	   or	   significant	   changes	   in	   an	  
existing	  one,	  and	  therefore	  understanding	  the	  dynamics	  of	  market	  formation	   is	  here	  seen	  as	  
one	  of	  the	  generic	  competencies.	  An	  elaborate	  understanding	  of	  market	  formation	  processes	  
needs	   to	   take	   into	   account	   coevolution	  of	   the	   technological,	   institutional,	   political	   and	  user-­‐




formation	  is	  often	  described	  as	  proceeding	  from	  a	  nursing	  phase	  to	  a	  bridging	  phase	  to	  a	  mass	  
market	  (Jacobsson	  and	  Bergek	  2004),	  and	  each	  of	  these	  phases	  is	  associated	  with	  specific	  bar-­‐
riers	  and	  challenges	  (Dewald	  and	  Truffer	  2011,	  287).	   It	   is	  obvious,	  as	  Heinonen	  (forthcoming)	  
observes,	  that	  the	  set	  of	  the	  potential	  regenerative	  medicine-­‐related	  industries	  is	  quite	  wide,	  
and	   there	  are	  many	  paths	   from	  new	  knowledge	   to	   systematic	  production.	  According	   to	  him,	  
these	  are	  related	  to	  cell	  therapies,	  tissue	  engineering,	  gene	  therapy,	  tools	  and	  devices,	  regen-­‐
erative	  compounds,	  and	  aesthetics	  medicine	  (Mason,	  2007;	  Mason	  and	  Dunnill,	  2008;	  Parson	  
2008).	  Even	  though	  market	  formation	  is	  considered	  here	  as	  one	  of	  the	  generic	  competencies	  in	  
a	   competence	   set,	   its	  driving	   forces	  are	  more	  often	   than	  not	   considered	  as	  exogenously	  de-­‐
fined,	  and	  typically	  it	  is	  seen	  to	  follow	  linear	  change	  patterns.	  In	  practice,	  to	  push	  development	  
into	  new	  directions,	  various	  actors	  often	  need	   to	   innovate	  against	   the	   logic	  of	  an	   innovation	  
system	  that	  is	  supposed	  to	  support	  them	  (Hung	  and	  Whittington	  2011).	  	  
All	  in	  all,	  the	  human	  spare	  parts	  industry	  is	  still	  to	  emerge;	  market	  formation	  has	  barely	  be-­‐
gun.	  According	  to	  Bonfiglio	  (2014),	  there	  are	  approximately	  700	  regenerative	  medicine-­‐related	  
companies	  in	  the	  world,	  the	  dominant	  locations	  being	  the	  USA	  (56%)	  and	  the	  UK	  (19%).	  Li	  et	  al	  
(2014)	  estimate	  that,	  from	  1992	  to	  2012,	  there	  have	  been	  1,058	  novel	  stem	  cell	  clinical	  trials	  
globally,	  the	  share	  of	  the	  US	  being	  high.	  Since	  2006	  the	  number	  of	  clinical	  trials	  has	  been	   in-­‐
creasing	   rapidly	   in	   the	  Asian	  countries	  but	  also	   in	  South	  America.	  Especially	  China,	   India	  and	  
Brazil	  have	  invested	  heavily	  in	  research	  related	  to	  regenerative	  medicine	  with	  a	  target	  to	  take	  
the	  leading	  positions	  in	  the	  global	  competition	  from	  the	  very	  beginning	  (Salter	  2009;	  McMah-­‐
on	  and	  Thorsteinsdottir	  2013).	  	  
As	  Hekkert	  and	  Negro	  (2009,	  587)	  maintain,	  an	  innovation	  has	  to	  become	  part	  of	  an	  incum-­‐
bent	  regime.	  Sometimes	  new	  products	  or	  processes	  may	  even	  need	  to	  overthrow	  the	  existing	  
regime	   that	   frequently	   causes	   uncertainty	   and	   social	   anxiety.	   Simultaneously	   with	   the	   high	  
hopes	   generated	   by	   regenerative	  medicine,	   the	   emerging	   human	   spare	   parts	   industry	   faces	  
complex	  ethical	  and	  legislative	  issues	  and	  hence	  the	  emergence	  of	  it	  cannot	  be	  fully	  analyzed	  
without	  full	  appreciation	  of	  the	  issues	  related	  to	  legitimization.	  Reduction	  of	  social	  uncertainty	  
and	   resistance	   to	   change	   are	   among	   the	   competencies	   needed	   in	   an	   innovation	   ecosystem.	  
These	  are	  here	  combined	  under	  the	  concept	  of	  legitimization.	  Legitimization	  refers	  to	  the	  so-­‐
cio-­‐political	  process	  of	  legitimacy	  formation	  through	  actions	  by	  various	  organisations	  and	  indi-­‐
viduals.	   Central	   features	   are	   the	   formation	   of	   expectations	   and	   visions	   as	  well	   as	   regulative	  
alignment,	  including	  issues	  such	  as	  market	  regulations,	  tax	  policies	  of	  the	  directions	  of	  science	  
and	  policy.	  (Bergek	  et	  al	  2008)	  Legitimization	  is	  about	  acquiring	  a	  social	  acceptance	  of	  innova-­‐
tion,	  and	  it	  is	  a	  process	  that	  makes	  an	  innovation	  conform	  to	  the	  prevailing	  institutions	  (norms,	  
values,	  habits	  and	  regulations),	  and/or	  to	  a	  process	  that	  targets	  the	  change	  of	  institutions	  for	  
something	  new	  to	  emerge	  (Johnson	  2001).	  Therefore,	  legitimization	  is	  one	  of	  the	  most	  central	  
of	  the	  selection	  mechanisms	  in	  any	  innovation	  ecosystem.	  	  
Statutes	  concerning	  clinical	  medical	  research	  in	  general	  cover	  much	  of	  the	  stem	  cell-­‐based	  
research	  and	  only	  a	  few	  countries	  have	  adopted	  legislation	  devoted	  to	  stem	  cell	  research	  per	  
se.	  The	  legislation	  on	  stem	  cell	  research	  varies	  widely	  in	  Europe.	  In	  Finland,	  the	  ethical	  atmos-­‐




and	   Thorsteinsdottir	   (2013),	   there	   are	   significant	   differences	   in	   how	   the	   human	   embryonic	  
stem	   cells	   (hESC)	   are	   accepted	   for	   research	   purposes.	   For	   example,	   in	   Brazil,	   the	   Catholic	  
Church	  was	  against	  the	  use	  of	  the	  human	  embryonic	  stem	  cell	  and	  this	  caused	  significant	  con-­‐
sequences,	  but	  in	  China	  and	  India	  this	  kind	  of	  research	  is	  allowed	  (Salter	  2009;	  McMahon	  and	  
Thorsteinsdottir,	  2013).	  Even	  in	  the	  European	  Union	  different	  countries	  have	  different	  regula-­‐
tions	  regarding	  hESC.	  For	  example,	  the	  UK,	  Sweden	  and	  Belgium	  allow	  production	  of	  the	  hESC	  
lines,	  but	  in	  other	  EU	  countries	  it	  is	  more	  or	  less	  limited	  (Heinonen,	  forthcoming).	  It	  is	  virtually	  
impossible	   to	   fully	   appreciate	   the	   development	   and	   policy	   needs	   of	   regenerative	   medicine	  
without	  full	  scrutiny	  of	  issues	  related	  to	  legitimization.	  	  
Liu	   and	   White	   (2001)	   suggest	   that,	   in	   the	   spirit	   of	   demand-­‐led	   innovation,	   end-­‐use-­‐
generated	  innovation	  needs	  to	  be	  acknowledged.	  In	  the	  early	  stages	  of	  regenerative	  medicine-­‐
related	  products	  and	  services,	  it	  is	  fairly	  hard	  to	  see	  user-­‐	  or	  demand-­‐led	  innovation	  emerging.	  
The	  entire	  field	  is	  pushed	  forward	  by	  new	  developments	  in	  science,	  and	  the	  ‘customer	  imagi-­‐
nation’	   is	   not	   developed	   enough	   to	   demand	   new	   kinds	   of	   services.	   However,	   as	   the	   field	   is	  
characterized	  by	  high	  hopes	  and	  global	  hype,	   there	  are	  also	  a	  variety	  of	  expectations.	  Public	  
policymakers	   and	   funding	   bodies	   may	   look	   forward	   to	   increased	   employment	   and	   globally	  
leading	  positions	  in	  a	  new	  sexy	  field.	  Scientists,	  for	  their	  part,	  aim	  to	  push	  the	  scientific	  frontier	  
forward	  but	  also	  hunt	  for	  citations	  and	  fame.	  And	  of	  course,	  ultimately,	  there	  are	  incurable	  or	  
difficult	  to	  cure	  diseases,	  and	  thus	  there	  are	  plenty	  of	  patients	  who	  look	  forward	  to	  scientific	  
breakthroughs	  that	  might	  provide	  them	  with	  new	  hope.	  Innovation	  ecosystems,	  and	  potential	  
and	   actual	   beneficiaries	   of	   developments	   in	   them,	   consist	   of	   a	   heterogeneous	   set	   of	   actors	  
that	  all	  have	  their	  own	  hopes	  and	  fears.	  Therefore	  the	  primary	  function	  of	  an	  ecosystem,	  and	  
related	  expectations,	  are	  not	  as	  clear	  as	  we	  might	  assume;	  an	  innovation	  ecosystem	  is	  a	  nexus	  
of	  many	  expectations	  and	  objectives.	  Therefore,	  it	  is	  important	  to	  scrutinize	  what	  the	  potential	  
end	  results	  are	  by	  focusing	  not	  only	  on	  end-­‐use	  of	  specific	  innovations,	  or	  demand-­‐led	  innova-­‐
tion,	  but	  the	  end-­‐values	  various	  actors	  expect	  to	  get	  out	  of	  an	  innovation	  ecosystem.	  Thus	  it	  is	  
important	  to	  note	  that	   ‘a	  firm’	   is	  not	  an	  end-­‐value,	  as	   is	  often	  seen,	  but	  the	  value	  generated	  
for	   the	   society,	   economy,	   innovation	  ecosystem	  and/or	   the	   customers.	   Firms,	  of	   course,	   are	  





TABLE	  1.	  The	  core	  definitions	  related	  to	  generic	  competencies	  (own	  definitions	  based	  on	  Shane	  
and	  Venkataraman	  2000;	  Hekkert	  et	  al	  2007;	  Hekkert	  and	  Negro	  2009;	  Johnson	  2001;	  Bergek	  
et	  al	  2008)	  and	  the	  main	  questions	  guiding	  the	  research.	  
Competence	   Definition	   Questions	  (examples)	  
Knowledge	  develop-­‐
ment	  
The	  breadth	  and	  depth	  of	  the	  for-­‐
mal	  and	  informal	  knowledge	  bases	  
and	  the	  ways	  knowledge	  is	  generat-­‐
ed,	  diffused	  and	  combined	  in	  the	  
ecosystem	  
What	  are	  knowledge	  dynamics	  like?	  
How	  is	  new	  knowledge	  diffused;	  what	  
channels	  are	  used?	  
Venture	  finances	   Monetary	  investment	  to	  support	  
the	  start	  of	  something	  new	  or	  dif-­‐
ferent	  that	  usually	  involves	  risk	  
What	  are	  the	  most	  important	  private	  
and	  public	  funding	  bodies	  and	  how	  do	  
they	  function?	  How	  is	  the	  funding	  
provided?	  
Entrepreneurship	   The	  discovery	  and	  exploitation	  of	  
profitable	  opportunities	  
What	  factors	  support	  and	  constrain	  
entrepreneurship?	  How	  do	  entrepre-­‐
neurs	  build	  market	  understanding	  for	  
selection	  pf	  the	  most	  prominent	  op-­‐
portunities,	  on	  the	  one	  hand,	  and	  
creating	  them	  on	  the	  other	  hand?	  
Legitimization	   Acquiring	  social	  acceptance	  of	  inno-­‐
vation	  that	  is	  a	  socio-­‐political	  pro-­‐
cess,	  central	  features	  being	  the	  
formation	  of	  expectations	  and	  vi-­‐
sions	  as	  well	  as	  regulative	  alignment	  
to	  support	  emergence	  of	  new	  
sources	  of	  economic	  growth	  and	  
renewal	  	  
What	  is	  the	  socio-­‐political	  situation	  in	  
a	  given	  field	  like,	  and	  in	  what	  ways	  
may	  emergence	  of	  innovation	  be	  
supported	  through	  a	  consciously	  de-­‐
fined	  legitimization	  process?	  
Market	  formation	   The	  ways	  economic	  activity,	  and	  
especially	  the	  forces	  of	  supply	  and	  
demand,	  interact	  and	  change	  in	  
time	  
What	  is	  the	  size	  of	  market,	  who	  are	  
the	  leading	  players	  and	  where	  are	  the	  
dominant	  locations	  in	  the	  field	  in	  
question?	  How	  do	  new	  markets	  
emerge	  and	  existing	  markets	  trans-­‐
form?	  
Systematic	  production	   Innovation	  becomes	  part	  of	  the	  
economy	  and	  society	  at	  large	  with	  
organized	  regularity	  that	  forms	  a	  
system	  	  
How	  are	  innovations	  institutionalized?	  
End-­‐value	   The	  desirability	  and/or	  worth	  of	  an	  
innovation	  for	  users	  of	  it	  
What	  are	  the	  whole	  array	  of	  potential	  
users	  and	  benefits	  of	  an	  innovation	  
like?	  Of	  course,	  it	  is	  by	  default	  impos-­‐
sible	  to	  know	  what	  end-­‐values	  un-­‐
known	  products	  and	  processes	  will	  
generate	  in	  the	  future	  but	  it	  is	  im-­‐
portant	  to	  discuss	  the	  ways	  different	  
societal	  groups	  may	  be	  affected	  by	  






This	   paper	   suggests	   that	   to	   truly	   understand,	   firstly,	   how	   industries	   evolve	   and	   change,	   and	  
secondly,	  how	  universities	  contribute	   to	   their	   transformation,	   there	   is	  a	  need	  to	   focus	  on	  an	  
entire	   innovation	  ecosystem	  and	  analyse	  interacting	  and	  conflicting	  competencies	  that	  either	  
enhance	  or	  hamper	  the	  overall	  evolution.	  In	  this	  paper,	  for	  empirical	  analysis,	  a	  set	  of	  generic	  
competencies	  was	   introduced.	   The	  dominant	   competencies	   are	   related	   to	   the	   generation	  of	  
new	  knowledge	  and	  the	  selection	  of	  winning	  knowledge,	  products	  and/or	  services	  and	  reten-­‐
tion	  of	  them	  in	  the	  economy.	  The	  competence	  set	  model	  discussed	  here	  is	  in	  a	  very	  early	  stage	  
of	  development,	  and	  only	  after	  proper	  empirical	  testing	  and	  operationalization	  of	  the	  generic	  
competencies	   in	   relation	  to	  each	  other	  will	   it	  be	  possible	   to	  say	  anything	  definitive	  about	   its	  
usefulness	   in	  research	  and	   in	   innovation	  policy.	  The	  assumption	  here	   is	  that	  the	  competence	  
set	  determines	  the	  dynamism	  of	  an	  innovation	  ecosystem.	  
For	  an	  innovation	  ecosystem	  to	  self-­‐propel	  into	  a	  growing	  industry,	  the	  various	  competen-­‐
cies	  are	  supposed	  to	  support	  each	  other,	  and	  not	  be	  in	  conflict.	  The	  policy	  problem	  therefore	  
concerns	  whether	   policy	   catalysts	   can	   be	   inserted	   to	   initiate	   a	   competence,	   change	   existing	  
ones	  or	  to	  make	  them	  more	  in	  line	  with	  each	  other.	  All	  this	  requires,	  as	  Avnimelech	  and	  Teubal	  
(2008)	  maintain,	  customized	  and	  discrete	  policy	  interventions	  that	  are	  directed	  at	  varying	  are-­‐
as	   of	   system/market	   failure	   that	   emerge	   at	   difference	   phases	   of	   the	   overall	   evolution	   of	   an	  
innovation	  ecosystem.	  A	  competence	  set	  with	  an	  evolutionary	  understanding	  provides	  policy-­‐
makers	   with	   knowledge	   about	   how	   to	   detect	   the	   need	   and	   timing	   for	   interventions.	  
Avnimelech	  and	  Teubal	  (2008)	  propose	  further	  that	  implementation	  of	  a	  policy	  “in	  crucial	  tran-­‐
sition	  points	   of	  market-­‐led	   development	   processes	   could	   have	   a	   significant	   influence	  on	   the	  
effectiveness	  of	  market	  forces”	  and	  that	  “policy	  targeting	  is	  often	  based	  on	  leveraging	  the	  suc-­‐
cess	   of	   key	  market	   agents	   in	   a	   particular	   area”.	   Indeed,	   this	   is	  why	  we	   need	   to	   identify	   the	  
competencies	   that	  make	   innovation	   ecosystems	   function	  well.	   Their	  main	   contribution	   is	   to	  
provide	  added	  knowledge	  of	  how	  to	  target	  customized	   innovation	  policies	   (cf.	  Sotarauta	  and	  
Kosonen	   2013)	   and	   to	   help	   universities	   position	   themselves	   in	   innovation	   ecosystems.	   The	  
Tampere	  case	  shows	  how	  difficult	  it	  is	  to	  move	  beyond	  science	  in	  an	  emerging	  field,	  in	  which	  
not	  all	  the	  competencies	  have	  developed	  yet.	  It	  is	  clear	  that	  the	  role	  of	  universities	  is	  crucial	  in	  
the	  emergence	  of	  the	  human	  spare	  parts	  industry,	  as	  they	  possess	  the	  main	  knowledge	  crea-­‐
tion	   competencies	   but,	   as	   Heinonen	   (forthcoming)	   summarizes,	   with	   the	   emergence	   of	   the	  
human	  spare	  industry,	  the	  main	  obstacles	  are	  related	  to	  insufficient	  funding,	  difficulties	  in	  the	  
technology	  transfer	  processes	  and	  issues	  related	  to	  intellectual	  property,	  poor	  understanding	  
of	  emerging	  markets	  and	  acquisition	  of	  capabilities	  needed	  in	  a	  new	  field.	  Many	  of	  these	  issues	  
are	  beyond	  what	  can	  be	  expected	  from	  universities,	  and	  quite	  naturally	  the	  emergence	  of	  the	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